a 30-year-old gravida 2, para 1 client is admitted to the hospital at 26-weeks gestation in preterm labor. she is given a dose of terbutaline sulfate (brethine) 0.25 mg subcutaneous. which assessment is the highest priority for the nurse to monitor during the administration of this drug?
